El CRAI romandrà tancat del 24 de desembre de 2025 al 6 de gener de 2026. La validació de documents es reprendrà a partir del 7 de gener de 2026.
El CRAI permanecerá cerrado del 24 de diciembre de 2025 al 6 de enero de 2026. La validación de documentos se reanudará a partir del 7 de enero de 2026.
From 2025-12-24 to 2026-01-06, the CRAI remain closed and the documents will be validated from 2026-01-07.
 
Miniatura

Fitxers

663906.pdf (919.67 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2015-09-02

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/106045

Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathway

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1136/annrheumdis-2015-208154

Resum

OBJECTIVES: TYK2 is a common genetic risk factor for several autoimmune diseases. This gene encodes a protein kinase involved in interleukin 12 (IL-12) pathway, which is a well-known player in the pathogenesis of systemic sclerosis (SSc). Therefore, we aimed to assess the possible role of this locus in SSc. METHODS: This study comprised a total of 7103 patients with SSc and 12 220 healthy controls of European ancestry from Spain, USA, Germany, the Netherlands, Italy and the UK. Four TYK2 single-nucleotide polymorphisms (V362F (rs2304256), P1104A (rs34536443), I684S (rs12720356) and A928V (rs35018800)) were selected for follow-up based on the results of an Immunochip screening phase of the locus. Association and dependence analyses were performed by the means of logistic regression and conditional logistic regression. Meta-analyses were performed using the inverse variance method. RESULTS: Genome-wide significance level was reached for TYK2 V362F common variant in our pooled analysis (p=3.08×10(-13), OR=0.83), while the association of P1104A, A928V and I684S rare and low-frequency missense variants remained significant with nominal signals (p=2.28×10(-3), OR=0.80; p=1.27×10(-3), OR=0.59; p=2.63×10(-5), OR=0.83, respectively). Interestingly, dependence and allelic combination analyses showed that the strong association observed for V362F with SSc, corresponded to a synthetic association dependent on the effect of the three previously mentioned TYK2 missense variants. CONCLUSIONS: We report for the first time the association of TYK2 with SSc and reinforce the relevance of the IL-12 pathway in SSc pathophysiology.

Matèries

Citoquines, Genètica humana, Genètica mèdica, Malalties autoimmunitàries, Polimorfisme genètic

Matèries (anglès)

Cytokines, Human genetics, Medical genetics, Autoimmune diseases, Genetic polymorphisms

Citació

Col·leccions

Articles publicats en revistes (Medicina)

Citació

LÓPEZ ISAC, Elena, CAMPILLO DAVO, Diana, BOSSINI CASTILLO, Lara, GUERRA, Sandra g., ASSASSI, Shervin, SIMEÓN AZNAR, Carmen pilar, CARREIRA, Patricia, ORTEGO CENTENO, Norberto, GARCÍA DE LA PEÑA, Paloma, BERETTA, Lorenzo, SANTANIELLO, Alessandro, BELLOCCHI, Chiara, LUNARDI, Claudio, MORONCINI, Gianluca, GABRIELLI, Armando, RIEMESTAKEN, Gabriela, WITTE, Torsten, HUNZELMANN, Nicolas, KREUTER, Alexander, DISTLER, Jörg h.v., VOSKUYL, Alexandre e., VRIES-BOUWSTRA, Jeska de, HERRICK, Ariane l., WORTHINGTON, Jane, DENTON, Christopher p., FONSECA, Carmen, RADSTAKE, Timothy r.d.j., MAYES, Maureen d., MARTÍN, Javier, Spanish Scleroderma Study Group (SSSG), ESPINOSA GARRIGA, Gerard. Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathway. _Annals of the Rheumatic Diseases_. 2015. Vol. 75, núm. 8, pàgs. 1521-1526. [consulta: 7 de gener de 2026]. ISSN: 0003-4967. [Disponible a: https://hdl.handle.net/2445/106045]

Exportar metadades

JSON - METS

Compartir registre